137 related articles for article (PubMed ID: 1706786)
1. Production of monoclonal antibody against human prostatic adenocarcinoma and its immunohistochemical properties.
Matsuki H; Ozono S; Yoshie T; Kubota K; Hirao Y; Konishi N; Hashimoto H; Ohshima M; Hiasa Y; Okajima E
Jpn J Exp Med; 1990 Oct; 60(5):263-72. PubMed ID: 1706786
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
[TBL] [Abstract][Full Text] [Related]
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
4. Human prostate tissue antigens defined by murine monoclonal antibodies.
Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
[TBL] [Abstract][Full Text] [Related]
8. [A monoclonal antibody that reacts with an antigen on both normal and malignant prostate cells].
Dou L; Yu L; Xing N; Ding Y; Deng F; Guo Y
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):234-6, 44. PubMed ID: 11825376
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen].
Mathieu MC; Caillaud JM
Bull Cancer; 1985; 72(5):405-13. PubMed ID: 2416371
[TBL] [Abstract][Full Text] [Related]
10. Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma.
Myers RB; Srivastava S; Grizzle WE
J Urol; 1995 May; 153(5):1572-4. PubMed ID: 7714977
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
12. [Study of growth fraction on fine needle aspirated prostatic tissue smear using monoclonal antibody Ki-67].
Sai S; Takashi M; Miyake K; Koshikawa T
Hinyokika Kiyo; 1991 Aug; 37(8):881-6. PubMed ID: 1957731
[TBL] [Abstract][Full Text] [Related]
13. Production of monoclonal antibody alpha Pro3 recognizing a human prostatic carcinoma antigen.
Ware JL; Paulson DF; Parks SF; Webb KS
Cancer Res; 1982 Apr; 42(4):1215-22. PubMed ID: 6174221
[TBL] [Abstract][Full Text] [Related]
14. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer-associated markers.
Chu TM
Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
[TBL] [Abstract][Full Text] [Related]
16. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the HNK-1 (Leu-7) antigen in prostatic cancer--an immunohistochemical study.
Liu XH; Yoshiki T; Kokuho M; Okada Y; Tomoyoshi T; Higuchi K
Hinyokika Kiyo; 1993 May; 39(5):439-44. PubMed ID: 7686713
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
